Hanall Biopharma Co (XKRX:009420) Price-to-Operating-Cash-Flow : 134.44 (As of Jul. 03, 2025)

View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Price-to-Operating-Cash-Flow?

As of today (2025-07-03), Hanall Biopharma Co's share price is ₩25000.00. Hanall Biopharma Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩185.96. Hence, Hanall Biopharma Co's Price-to-Operating-Cash-Flow Ratio for today is 134.44.

The historical rank and industry rank for Hanall Biopharma Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

XKRX:009420' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 26.15 Med: 110.44 Max: 21909.42
Current: 134.43

During the past 13 years, Hanall Biopharma Co's highest Price-to-Operating-Cash-Flow Ratio was 21909.42. The lowest was 26.15. And the median was 110.44.

XKRX:009420's Price-to-Operating-Cash-Flow is ranked worse than
92.98% of 684 companies
in the Drug Manufacturers industry
Industry Median: 18.215 vs XKRX:009420: 134.43

Hanall Biopharma Co's Cash Flow from Operations per share for the three months ended in Mar. 2025 was ₩16.74. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩185.96.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hanall Biopharma Co was -55.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 124.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 32.90% per year.

During the past 13 years, Hanall Biopharma Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 217.90% per year. The lowest was -78.60% per year. And the median was 39.60% per year.

Hanall Biopharma Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Hanall Biopharma Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Price-to-Operating-Cash-Flow Chart

Hanall Biopharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

2,066.23

1,281.43

35.44

75.99

209.41

Hanall Biopharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															88.82	69.97	225.06	209.41	147.61

Competitive Comparison of Hanall Biopharma Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Hanall Biopharma Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hanall Biopharma Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanall Biopharma Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hanall Biopharma Co's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Hanall Biopharma Co Price-to-Operating-Cash-Flow Calculation

Hanall Biopharma Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	25000.00	/	185.958
	=	134.44

Hanall Biopharma Co's Share Price of today is ₩25000.00.
Hanall Biopharma Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩185.96.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Hanall Biopharma Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Hanall Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Price-to-Operating-Cash-Flow

Traded in Other Exchanges

N/A

Address

12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR

Website

http://www.hanall.co.kr

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co Headlines

No Headlines